Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | CuttingEdgeInfo Reports | Thought Leader Fair-Market Value Compensation Benchmarks and Procedures (PH121)

Thought Leader Fair-Market Value Compensation Benchmarks and Procedures (PH121)

Thought Leader FMV: Compensation and Procedures

Thought leader management teams face many new challenges in today's environment. Academic institutions have implemented new regulations limiting or, in some cases, forbidding their faculty's relationships with drug manufacturers. Individual states continue to call for more transparency of the industry's payments to physicians. And industry trade groups, such as PhRMA, and medical associations, such as the ACCME, have revised their guidelines to limit drug makers' involvement in physician activities.

These and other changes have left companies targeting a smaller pool of key opinion leaders. Calls for greater transparency have forever changed how pharmaceutical and biotechnology companies compensate thought leaders. With increased transparency, however, comes a new set of challenges. Given this trend, thought leader management teams now focus on their processes to determine fair-market value compensation, knowing that a documented process is as important as the actual fees paid to physicians.

Cutting Edge Information's latest fair-market value report provides clear procedures for calculating fair-market value compensation. Thought Leader Fair-Market Value: Compensation Benchmarks and Procedures is backed by more than 85 top pharmaceutical, biotechnology and medical device companies' and third-party providers' data. Furthermore, the study's analysis provides relevant case studies and best practices to guide any team that works with thought leaders and KOLs.

Cutting Edge Information has emerged as a leader in providing fair-market value research. Thought Leader Fair-Market Value: Compensation Benchmarks and Procedures is the most comprehensive, high-quality syndicated collection of fair-market value benchmarks available today. The data in this report covers 17 different thought leader and medical professional categories, 19 therapeutic areas, as well as benchmarks for small, mid-size, large and medical device companies. Start improving your thought leader development processes now with this brand new study.

Companies Included in Report

More than 85 companies' fair-market value benchmarks.

The surveyed companies provided primary information either in the form of survey data or a telephone interview. Cutting Edge Information's analysts use secondary data to supplement the information provided by study participants. Surveyed companies include five top-20 and eight top-40 pharmaceutical companies, as well as biotechnology companies, medical device firms and third-party providers.

Therapeutic Areas Included in Report

Cutting Edge Information's data cover 19 therapeutic areas. As a group, participants provided more data for some therapeutic areas than others. This research covers thought leader compensation for these therapeutic areas:

Therapeutic Areas

* Autoimmune

* Cardiology and Thrombosis

* Central Nervous System (CNS)/Psychology

* Consumer Products

* Dermatology

* Diabetes (Type 1)

* Diabetes (Type 2)

* Gastroenterology

* Hematology

* Infectious Diseases

* Inflammation

* Lifestyle Medications

* Medical Devices

* Musculoskeletal

* Oncology

* Radiology

* Respiratory

* Urology

* Women's Health

Published 2009

472 Pages

1000+ Metrics

250+ Tables, Charts and Diagrams

Table of Contents
Price: $7,695.00 / €5,143.34

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions